Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Integrated disk driving module including a stepping motor integrally formed with a base unit
Power storage device and method for manufacturing the same
Systems and methods for reducing narrow bandwidth interference contained in broad bandwidth signals
Field device for determining or monitoring a physical or chemical process variable
Distortion compensation device, distortion compensation method, and radio transmitter
Digital fine delay processing
Fuse part in semiconductor device and method for forming the same
  Randomly Featured Patents
Mutli-functional photometer with movable linkage for routing optical fibers
Neck and head of a housing for a free-standing evaporative cooling unit
Disc brake having a piston retraction assembly
System and method for controlling vehicle operation in response to fuel vapor purging
Method, apparatus, and system for remote baby monitoring with additional functions
Techniques for enhanced reliability of data transfer with dynamic scaling
RSV specific binding molecule
Charge pump circuit, nonvolatile memory, data processing apparatus, and microcomputer application system
Electrical component support structure
Information storage semiconductor element